title: Overcoming biological, behavioral, and structural vulnerabilities: new directions in research to decrease HIV transmission in men who have sex with men.
abstract: Men who have sex with men (MSM), including transgender women, comprise a heterogeneous group of individuals whose sexual behaviors and gender identities may vary widely between cultures and among individuals. Their sources of increased vulnerability to HIV are diverse, including the increased efficiency of HIV transmission via unprotected anal intercourse, sexual role versatility, asymptomatic sexually transmitted infections, and behavioral factors that may be associated with condomless sex with multiple partners. Societal stigmatization of homosexual behavior and gender nonconformity may result in internalized negative feelings that lead to depression, other affective disorders, and substance use, which in turn are associated with increased risk-taking behaviors. Social stigma and punitive civil environments may lead to delays in seeking HIV and sexually transmitted disease screening, and later initiation of antiretroviral therapy. The iPrEX study demonstrated that chemoprophylaxis can decrease HIV acquisition in MSM, and the HIV prevention trials network 052 study established the biological plausibility that earlier initiation of highly active antiretroviral therapy can decrease HIV transmission to uninfected partners. Despite these advances, MSM remain among the most significantly HIV-affected population in resource-rich and limited settings. New studies will integrate enhanced understanding of the biology of enhanced rectal transmission of HIV and the focused use of antiretrovirals for prevention with culturally tailored approaches that address the potentiating social and behavioral factors associated with enhanced HIV spread among MSM.
authors.affiliation: Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. kmayer@fenwayhealth.org
authors.forename: Kenneth H
authors.initials: KH
authors.lastname: Mayer
authors.forename: Darrell P
authors.initials: DP
authors.lastname: Wheeler
authors.forename: Linda-Gail
authors.initials: LG
authors.lastname: Bekker
authors.forename: Beatriz
authors.initials: B
authors.lastname: Grinsztejn
authors.forename: Robert H
authors.initials: RH
authors.lastname: Remien
authors.forename: Theodorus G M
authors.initials: TG
authors.lastname: Sandfort
authors.forename: Chris
authors.initials: C
authors.lastname: Beyrer
mesh_terms: D000293:Adolescent; D000328:Adult; D000341:Affective Disorders, Psychotic; D000349:Africa; D044966:Anti-Retroviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001208:Asia; D003863:Depression; D005260:Female; D005783:Gender Identity; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control / Q000635:transmission*; D018451:Homosexuality, Male / Q000523:psychology*; D006801:Humans; D007843:Latin America; D008297:Male; D008875:Middle Aged; D011322:Primary Prevention; D012309:Risk-Taking; D012725:Sexual Behavior; D012747:Sexual Partners; D013240:Stereotyping; D063106:Transgender Persons / Q000523:psychology*; D055815:Young Adult
chemical_list: D044966:Anti-Retroviral Agents